Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN).

Full DD Report for SUPN

You must become a subscriber to view this report.


Recent News from (NASDAQ: SUPN)

Biotechs Emerge Unscathed And Ready To Go!
Biotech Pulse Biotechs have a pulse now, and it's beginning to beat a little harder! As President Trump on Friday, May 11, delivered a blueprint, American Patients First , to lower drug prices the early indications appear to be that the biotech and pharmaceutical industries have jumped th...
Source: SeekingAlpha
Date: May, 15 2018 08:28
Today's Research Reports on Stocks to Watch: Intrexon and Supernus Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / May 14, 2018 / While one biotech company went up, the other went down on Friday. Intrexon shares tanked on Friday over first quarter results that didn’t impress traders, as shares of Supernus Pharmaceuticals were galloping ahead on a strong first quarter r...
Source: ACCESSWIRE IA
Date: May, 14 2018 08:00
Supernus Pharmaceuticals' (SUPN) CEO, Jack Khattar on Q1 2018 Results - Earnings Call Transcript
Supernus Pharmaceuticals Inc. (SUPN) Q1 2018 Earnings Conference Call May 9, 2018 9:00 am ET Executives Jack Khattar - President, Chief Executive Officer Gregory Patrick - Chief Financial Officer Peter Vozzo - Westwicke Partners Analysts Ken Cacciatore - Cowen & Co. D...
Source: SeekingAlpha
Date: May, 09 2018 13:12
Supernus Pharmaceuticals beats by $0.16, beats on revenue
Supernus Pharmaceuticals (NASDAQ: SUPN ): Q1 EPS of $0.49 beats by $0.16 . More news on: Supernus Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 08 2018 16:42
Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue
Total revenue of $90.4 million, a 57% increase over 2017 Net product sales of $89.1 million, a 58% increase over 2017 Operating earnings of $31.4 million, an 87% increase over 2017 Diluted earnings per share (GAAP) of $0.49, compared to $0.19 in 2017 ROCKVILLE, Md., May 08, 201...
Source: GlobeNewswire
Date: May, 08 2018 16:40
How To Play 'Am I Diversified?' In The Pharma/Biotech Space
Background Many investors (including myself) regularly watch or listen to the show "Mad Money" by Jim Cramer on CNBC. As with any celebrity, Mr. Cramer tends to be polarizing, with some loving him and some reveling in pointing out when he is wrong. Rather than focusing on his individual stoc...
Source: SeekingAlpha
Date: May, 03 2018 00:54
Supernus to Host First Quarter 2018 Earnings Conference Call
ROCKVILLE, Md., April 24, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to repo...
Source: GlobeNewswire
Date: April, 24 2018 16:15
Biotechs, Whipsawed By Volatility, Still Remain Well-Positioned
Biotech Pulse When the market experiences rain, biotechs experience a thunderstorm. That's how volatility relates to biotechnology - one of the most promising and nerve-wracking industries in the stock market. As the market succumbed last week to the drumbeat of a tariff war, volatility sp...
Source: SeekingAlpha
Date: April, 13 2018 09:17
Factors of Influence in 2018, Key Indicators and Opportunity within Harmonic, Supernus Pharmaceuticals, America First Multifamily Investors, Ballard Power, ServiceSource International, and Materialise NV - New Research Emphasizes Economic Growth
NEW YORK, April 11, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Harmonic Inc. (NASDAQ:HLIT), Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN...
Source: GlobeNewswire
Date: April, 11 2018 07:45
Looking For Action? S&P 1500 Most Volatile Stocks
For traders with a short-term time horizon looking for big moves, we have updated our list of the S&P 1500 stocks trading above $10 that have the largest intraday high-low ranges (based on the average percent spread between the intraday high and low over the last 50 days). The stocks are g...
Source: SeekingAlpha
Date: March, 29 2018 04:21

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1758.4556.5058.8055.951,135,878
2017-03-1027.3526.4027.4526.2571,484
2017-03-0927.8527.3528.07927.05595,080
2017-03-0826.5527.8028.5026.401,022,626
2017-03-0729.4526.4029.4525.002,946,700

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-2136,294117,96030.7681Cover
2018-08-2010,98373,70514.9013Cover
2018-08-1771,358211,03633.8132Cover
2018-08-1684,593314,35726.9099Cover
2018-08-1556,659224,80425.2037Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SUPN.


About Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

Logo for Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: SUPN)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 17 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 11 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 10 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 08 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 27 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 25 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 20 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 14 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 07 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 05 2018

       

       


      Daily Technical Chart for (NASDAQ: SUPN)

      Daily Technical Chart for (NASDAQ: SUPN)


      Stay tuned for daily updates and more on (NASDAQ: SUPN)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: SUPN)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SUPN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of SUPN and does not buy, sell, or trade any shares of SUPN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/